STOCK TITAN

Newhold Invt Corp III - NHICU STOCK NEWS

Welcome to our dedicated page for Newhold Invt III news (Ticker: NHICU), a resource for investors and traders seeking the latest updates and insights on Newhold Invt III stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Newhold Invt III's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Newhold Invt III's position in the market.

Rhea-AI Summary

NewHold Investment Corp. II (NHICU) announced shareholder approval for the "Extension Amendment" and "Termination Amendment" allowing the Board discretion to extend proxy filing dates and redeem public shares. However, the Board has chosen not to effectuate these amendments. On December 24, 2022, NHIC II's sponsor entered a Backstop Agreement to fund up to $1 million for any excise tax liabilities arising from liquidation under the Inflation Reduction Act of 2022. The Board continues to pursue a business combination, citing strong deal opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

NewHold Investment Corp. II (NASDAQ: NHICU) has filed a proxy statement seeking stockholder approval for two amendments to its Charter. The ‘Extension Amendment’ extends the proxy filing deadline for business combinations from April 25, 2023, to June 25, 2023. The ‘Termination Amendment’ allows NHIC to redeem public shares and liquidate as early as December 28, 2022. The company aims to navigate challenging market conditions that may hinder merger announcements. A special stockholder meeting is scheduled for December 20, 2022, to vote on these amendments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

NewHold Investment Corp. II has successfully closed its initial public offering (IPO) of 17,500,000 units priced at $10.00 each, with trading commencing on Nasdaq under the symbol “NHICU” on October 21, 2021. Each unit comprises one share of Class A common stock and half of a redeemable warrant, exercisable at $11.50 per share. The company plans to utilize the proceeds for its initial business combination, targeting firms in the industrial technology sector with an enterprise value of at least $700 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

NewHold Investment Corp. II announced the pricing of its initial public offering (IPO) of 17,500,000 units at $10.00 per unit, set to trade under the ticker symbol NHICU on Nasdaq starting October 21, 2021. Each unit includes one Class A common stock and half a redeemable warrant. The offering is expected to close on October 25, 2021. Stifel acts as the book-running manager, with a 45-day option for underwriters to purchase an additional 2,625,000 units. NewHold focuses on merging with businesses in industrial technology valued at over $700 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of Newhold Invt III (NHICU)?

The current stock price of Newhold Invt III (NHICU) is $10.02 as of February 28, 2025.
Newhold Invt Corp III

Nasdaq:NHICU

NHICU Rankings

NHICU Stock Data

17.50M